Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma

Abstract Background The anti-tumor properties of cannabinoids have been investigated in many in vitro and in vivo studies. Many of these anti-tumor effects are mediated via cannabinoid receptor types 1 and 2 (CB1 and CB2), comprising the endocannabinoid system (ECS). In this study, we investigated t...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Mohammed I. Khan, Anna A. Sobocińska, Klaudia K. Brodaczewska, Katarzyna Zielniok, Malgorzata Gajewska, Claudine Kieda, Anna M. Czarnecka, Cezary Szczylik
Format:	Article
Language:	English
Published:	BMC 2018-05-01
Subjects:	Renal cell carcinoma Endocannabinoid system (ECS) CB1 and CB2 receptors JWH-133 WIN 55,212–2 mesylate
Online Access:	http://link.springer.com/article/10.1186/s12885-018-4496-1